Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
26 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Eagle Pharmaceuticals Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Eagle Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Eagle Pharmaceuticals Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Eagle Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Eagle Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Eagle Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Eagle Pharmaceuticals Inc.'s pipeline products Reasons to buy - Evaluate Eagle Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Eagle Pharmaceuticals Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Eagle Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Eagle Pharmaceuticals Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Eagle Pharmaceuticals Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Eagle Pharmaceuticals Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Eagle Pharmaceuticals Inc. Snapshot 4 Eagle Pharmaceuticals Inc. Overview 4 Key Information 4 Key Facts 4 Eagle Pharmaceuticals Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Eagle Pharmaceuticals Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Partnered Products 9 Partnered Products/Combination Treatment Modalities 10 Eagle Pharmaceuticals Inc. - Pipeline Products Glance 11 Eagle Pharmaceuticals Inc. - Late Stage Pipeline Products 11 Pre-Registration Products/Combination Treatment Modalities 11 Eagle Pharmaceuticals Inc. - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 Eagle Pharmaceuticals Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Eagle Pharmaceuticals Inc. - Drug Profiles 14 bendamustine hydrochloride RTD 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 bendamustine hydrochloride SI 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 EP-4104 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 bivalirudin 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 pemetrexed disodium 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Eagle Pharmaceuticals Inc. - Pipeline Analysis 19 Eagle Pharmaceuticals Inc. - Pipeline Products by Target 19 Eagle Pharmaceuticals Inc. - Pipeline Products by Route of Administration 20 Eagle Pharmaceuticals Inc. - Pipeline Products by Molecule Type 21 Eagle Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 22 Eagle Pharmaceuticals Inc. - Recent Pipeline Updates 23 Eagle Pharmaceuticals Inc. - Locations And Subsidiaries 24 Head Office 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 26 Disclaimer 26
List of Tables Eagle Pharmaceuticals Inc., Key Information 4 Eagle Pharmaceuticals Inc., Key Facts 4 Eagle Pharmaceuticals Inc. - Pipeline by Indication, 2014 6 Eagle Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 7 Eagle Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 8 Eagle Pharmaceuticals Inc. - Partnered Products in Pipeline, 2014 9 Eagle Pharmaceuticals Inc. - Partnered Products/ Combination Treatment Modalities, 2014 10 Eagle Pharmaceuticals Inc. - Pre-Registration, 2014 11 Eagle Pharmaceuticals Inc. - Phase I, 2014 12 Eagle Pharmaceuticals Inc. - Preclinical, 2014 13 Eagle Pharmaceuticals Inc. - Pipeline by Target, 2014 19 Eagle Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014 20 Eagle Pharmaceuticals Inc. - Pipeline by Molecule Type, 2014 21 Eagle Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2014 22 Eagle Pharmaceuticals Inc. - Recent Pipeline Updates, 2014 23
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.